Spots Global Cancer Trial Database for locally advanced breast carcinoma

Every month we try and update this database with for locally advanced breast carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Pre-analytical Factors Affecting ctDNA Analysis in Early and Locally Advanced Breast Cancer	NCT05945290	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Early Stage Bre... Locally Advance...	Biospecimen Col... Electronic Heal...	18 Years -	Mayo Clinic
Safety, Ultrasound Conspicuity, and Migration of Twinkling Markers in Patients With Locally Advanced Breast Cancer	NCT05547347	Anatomic Stage ... Locally Advance... Resectable Brea...	Magnetic Resona... Mammogram Ultrasound Ultrasound-Guid...	18 Years -	Mayo Clinic
Cryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer	NCT04249167	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Locally Advance... Metastatic Trip... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Atezolizumab Cryosurgery Nab-paclitaxel	18 Years -	Mayo Clinic
Three Doses of TAS-108 to Treat Recurrent or Recurrent Inoperable Breast Cancer	NCT00166543	Breast Cancer	TAS-108	18 Years -	SRI International
INCMGA00012 and Pelareorep for the Treatment of Metastatic Triple Negative Breast Cancer, IRENE Study	NCT04445844	Anatomic Stage ... Locally Advance... Metastatic Trip... Prognostic Stag... Triple-negative...	Pelareorep Quality-of-Life... Questionnaire A... Retifanlimab	18 Years -	Rutgers, The State University of New Jersey
INCMGA00012 and Pelareorep for the Treatment of Metastatic Triple Negative Breast Cancer, IRENE Study	NCT04445844	Anatomic Stage ... Locally Advance... Metastatic Trip... Prognostic Stag... Triple-negative...	Pelareorep Quality-of-Life... Questionnaire A... Retifanlimab	18 Years -	Rutgers, The State University of New Jersey
Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer	NCT01463072	Locally Advance... Metastatic Brea... Recurrent Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast...	Laboratory Biom... Nab-paclitaxel Questionnaire A...	65 Years -	City of Hope Medical Center
Testing Olaparib Either Alone or in Combination With Atezolizumab in BRCA Mutant Non-HER2-positive Breast Cancer	NCT02849496	Anatomic Stage ... Anatomic Stage ... Locally Advance... Locally Advance... Metastatic Brea... Metastatic HER2... Unresectable Br... Unresectable HE...	Atezolizumab Biopsy Biospecimen Col... Bone Marrow Asp... Bone Marrow Bio... Bone Scan Computed Tomogr... Magnetic Resona... Olaparib Positron Emissi... Questionnaire A... X-Ray Imaging	18 Years -	National Cancer Institute (NCI)
Three Doses of TAS-108 to Treat Recurrent or Recurrent Inoperable Breast Cancer	NCT00166543	Breast Cancer	TAS-108	18 Years -	SRI International
Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer	NCT01463072	Locally Advance... Metastatic Brea... Recurrent Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast...	Laboratory Biom... Nab-paclitaxel Questionnaire A...	65 Years -	City of Hope Medical Center
Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer	NCT03101748	Breast Inflamma... Locally Advance... Metastatic Brea... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast...	Cyclophosphamid... Doxorubicin Laboratory Biom... Neratinib Paclitaxel Pertuzumab Trastuzumab	18 Years -	M.D. Anderson Cancer Center
Monitoring Neoadjuvant Chemotherapy of Breast Cancer Using 3D Subharmonic Aided Pressure Estimation	NCT04715958	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Locally Advance... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag...	Contrast-Enhanc... Perflutren Lipi...	21 Years -	Thomas Jefferson University
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations	NCT04550494	Advanced Pancre... Anatomic Stage ... Anatomic Stage ... Castration-Resi... Clinical Stage ... Clinical Stage ... HER2-Positive B... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Metastatic Brea... Metastatic Gast... Metastatic Mali... Metastatic Ovar... Metastatic Panc... Metastatic Pros... Platinum-Sensit... Stage II Pancre... Stage III Ovari... Stage III Pancr... Stage III Prost... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta...	Biopsy Biospecimen Col... Computed Tomogr... Magnetic Resona... Talazoparib	18 Years -	National Cancer Institute (NCI)
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma	NCT03941756	Anatomic Stage ... Breast Inflamma... Locally Advance... Melanoma	Indocyanine Gre... Lymphangiograph... Lymphovenous By...	18 Years -	M.D. Anderson Cancer Center
Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer	NCT04498520	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Hormone Recepto... Locally Advance... Metastatic Brea... Metastatic Endo... Metastatic Fall... Metastatic HER2... Metastatic Mali... Metastatic Ovar... Metastatic Prim... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Recurrent Fallo... Recurrent Ovari... Recurrent Prima... Refractory Brea... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... Stage IV Uterin... Stage IVA Fallo... Stage IVA Ovari... Stage IVA Prima... Stage IVA Uteri... Stage IVB Fallo... Stage IVB Ovari... Stage IVB Prima... Stage IVB Uteri...	Abexinostat Tos... Fulvestrant Palbociclib	18 Years -	University of California, San Francisco
Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer	NCT01149083	Anatomic Stage ... Anatomic Stage ... Locally Advance... Metastatic Brea... Unresectable Br...	Biopsy Biospecimen Col... Carboplatin Computed Tomogr... Magnetic Resona... Veliparib	18 Years -	National Cancer Institute (NCI)
Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer	NCT04498520	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Hormone Recepto... Locally Advance... Metastatic Brea... Metastatic Endo... Metastatic Fall... Metastatic HER2... Metastatic Mali... Metastatic Ovar... Metastatic Prim... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Recurrent Fallo... Recurrent Ovari... Recurrent Prima... Refractory Brea... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... Stage IV Uterin... Stage IVA Fallo... Stage IVA Ovari... Stage IVA Prima... Stage IVA Uteri... Stage IVB Fallo... Stage IVB Ovari... Stage IVB Prima... Stage IVB Uteri...	Abexinostat Tos... Fulvestrant Palbociclib	18 Years -	University of California, San Francisco
Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer	NCT01463072	Locally Advance... Metastatic Brea... Recurrent Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast...	Laboratory Biom... Nab-paclitaxel Questionnaire A...	65 Years -	City of Hope Medical Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: